Cargando…
Graves Disease Following the SARS-CoV-2 Vaccine: Case Series
Widespread vaccination is a principal strategy to mitigate the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and lessen the global burden of coronavirus disease 2019 (COVID-19). Information is rapidly evolving about the impact of SARS-CoV-2 vaccines on the immune and endocri...
Autores principales: | Weintraub, Michael A., Ameer, Barbara, Sinha Gregory, Naina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724979/ https://www.ncbi.nlm.nih.gov/pubmed/34939881 http://dx.doi.org/10.1177/23247096211063356 |
Ejemplares similares
-
Graves’ disease following SARS-CoV-2 vaccination
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2021) -
Graves’ disease following administration of second dose of SARS-CoV-2 vaccine
por: Goblirsch, Timothy James, et al.
Publicado: (2021) -
Graves’ Thyrotoxicosis Following SARS-CoV-2 Infection
por: Harris, Asaf, et al.
Publicado: (2020) -
New-onset Graves’ disease following SARS-CoV-2 vaccination: a case report
por: Manta, Ringo, et al.
Publicado: (2022) -
Graves’ Disease Following SARS-CoV-2 Vaccination: A Systematic Review
por: Patrizio, Armando, et al.
Publicado: (2022)